Oral enzyme combination with bromelain, trypsin and the flavonoid rutoside reduces systemic inflammation and pain when used pre- and post-operatively in elective total hip replacement: a randomized exploratory placebo-controlled trial
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
37529332
PubMed Central
PMC10387799
DOI
10.1177/1759720x231186875
PII: 10.1177_1759720X231186875
Knihovny.cz E-zdroje
- Klíčová slova
- C-reactive protein, bromelain, hip surgery, inflammation, oral enzyme combination, rutoside, total hip arthroplasty, trypsin,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Early mobilization after total hip replacement (THR) is key for fast recovery but is often limited by pain. Oral enzyme combinations (OECs) have demonstrated anti-inflammatory and pain-relieving effects. OBJECTIVES AND DESIGN: This prospective, randomized, double-blind, placebo-controlled exploratory trial evaluated the effects of pre- and post-operative use of OEC (90 mg bromelain, 48 mg trypsin, 100 mg rutoside) following elective THR, on post-operative recovery. METHODS: Candidates for primary elective cementless THR owing to osteoarthritis were eligible for participation [age ⩾50 years, body mass index 25-35 kg/m2, C-reactive protein (CRP) ⩽6 mg/L]. Following randomization to OEC or placebo, intervention started pre-operatively and continued onwards until day 42. Main outcomes included post-operative CRP levels (days 1-7), self-reported hip pain at rest (by 0-10 cm visual analogue scale on post-operative days 1-42), post-operative analgesic use [by cumulative analgesic consumption score (CACS) days 7-42], tolerability and adverse events. RESULTS: Patients (N = 34) were recruited from a tertiary orthopaedic hospital in the Czech Republic, of whom 33 completed the study (OEC/placebo: n = 15/18). Baseline characteristics across the groups were comparable. Compared with placebo, the OEC group had numerically lower CRP levels on post-operative days 1-7, including peak level [mean (standard deviation) OEC versus placebo: 81.4 (28.3) versus 106.7 (63.3) mg/L], which translated into a significant 32% lower CRP area under the curve (p = 0.034). The OEC group reported significantly less pain during post-operative days 1-7 versus placebo (analysis of variance treatment × visit [F(4) = 3.989]; p = 0.005). Analgesic use was numerically reduced as assessed through an accumulated CACS. No deleterious effects on haemorheological parameters were observed in either group. CONCLUSIONS: Pre- and post-operative use of OEC significantly reduced CRP levels and patient self-reported pain. OEC may be an efficacious and safe treatment option to facilitate post-operative recovery following THR. TRIAL REGISTRATION: EudraCT number 2016-003078-41.
Clinical Department for Trauma Surgery University Hospital Tulln Tulln Austria
Nestlé Health Science Avenue Nestle 55 Vevey Vaud 1800 Switzerland
Nestlé Health Science Vevey Switzerland
Orthopaedic and Traumatology Department Jihlava Hospital Jihlava Czech Republic
Rehabilitation Department Jihlava Hospital Jihlava Czech Republic
Zobrazit více v PubMed
OECD. Chapter 9: Healthcare activities: Hip and knee surgery. Health at a Glance 2019: OECD indicators. Paris: OECD Publishing, 2019, pp.198–199.
Singh JA, Yu S, Chen L, et al.. Rates of total joint replacement in the United States: Future projections to 2020–2040 using the National Inpatient Sample. J Rheumatol 2019; 46: 1134–1140. PubMed
Reyes C, Leyland KM, Peat G, et al.. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol 2016; 68: 1869–1875. PubMed PMC
The Lancet Gastroenterology & Hepatology. Obesity: another ongoing pandemic. Lancet Gastroenterol Hepatol 2021; 6: 411. PubMed PMC
Ackerman IN, Bohensky MA, de Steiger R, et al.. Lifetime risk of primary total hip replacement surgery for osteoarthritis from 2003 to 2013: a multinational analysis using national registry data. Arthritis Care Res 2017; 69: 1659–1667. PubMed
Wainwright TW, Gill M, McDonald DA, et al.. Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: enhanced recovery after surgery (ERAS(®)) Society recommendations. Acta Orthop 2020; 91: 3–19. PubMed PMC
National Institute for Health and Care Excellence. Joint replacement (primary): hip, knee and shoulder NICE guideline [NG157], https://www.nice.org.uk/guidance/ng157 (2020, accessed 20 December 2021). PubMed
Soffin EM, YaDeau JT. Enhanced recovery after surgery for primary hip and knee arthroplasty: a review of the evidence. Br J Anaesth 2016; 117: iii62–iii72. PubMed
Chua MJ, Hart AJ, Mittal R, et al.. Early mobilisation after total hip or knee arthroplasty: A multicentre prospective observational study. PLoS One 2017; 12: e0179820. PubMed PMC
Guerra ML, Singh PJ, Taylor NF. Early mobilization of patients who have had a hip or knee joint replacement reduces length of stay in hospital: a systematic review. Clin Rehabil 2015; 29: 844–854. PubMed
Molloy IB, Martin BI, Moschetti WE, et al.. Effects of the length of stay on the cost of total knee and total hip arthroplasty from 2002 to 2013. J Bone Joint Surg 2017; 99: 402–407. PubMed PMC
Gautreau S, Haley R, Gould ON, et al.. Predictors of farther mobilization on day of surgery and shorter length of stay after total joint arthroplasty. Can J Surg 2020; 63: e509–e516. PubMed PMC
Husted H, Lunn TH, Troelsen A, et al.. Why still in hospital after fast-track hip and knee arthroplasty? Acta Orthop 2011; 82: 679–684. PubMed PMC
Zhu S, Qian W, Jiang C, et al.. Enhanced recovery after surgery for hip and knee arthroplasty: a systematic review and meta-analysis. Postgrad Med J 2017; 93: 736–742. PubMed PMC
Frassanito L, Vergari A, Nestorini R, et al.. Enhanced recovery after surgery (ERAS) in hip and knee replacement surgery: description of a multidisciplinary program to improve management of the patients undergoing major orthopedic surgery. Musculoskelet Surg 2020; 104: 87–92. PubMed
Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol 2020; 180: 114147. PubMed PMC
Lotz-Winter H. On the pharmacology of bromelain: an update with special regard to animal studies on dose-dependent effects. Planta Med 1990; 56: 249–253. PubMed
Uhlig G, Seifert J. The effect of proteolytic enzymes (traumanase) on posttraumatic edema. Fortschr Med 1981; 99: 554–556. PubMed
Brown SA, Coimbra M, Coberly DM, et al.. Oral nutritional supplementation accelerates skin wound healing: a randomized, placebo-controlled, double-arm, crossover study. Plast Reconstr Surg 2004; 114: 237–244. PubMed
Kleine M. Evidence of the efficacy of an enzyme combination preparation using the method of artificial hematomas in combination with a pressure meter: A placebo controlled, randomised, prospective, double blind study. J Clin Res 1998; 1: 87–102.
Nanda MS, Kaur M. Role of oral enzymes in post operative septoplasty cases. Indian J Otolaryngol Head Neck Surg 2019; 71: 1663–1667. PubMed PMC
Lukáš J, Hroboň M, Kaňa R. Phlogenzym, systémová enzymoterapie u septoplastik. Choroby hlavy a krku 2000; 1: 7–9.
Shetty V, Mohan A. A prospective, randomized, double-blind, placebo-controlled clinical trial comparing the efficacy of systemic enzyme therapy for edema control in orthognathic surgery using ultrasound scan to measure facial swelling. J Oral Maxillofac Surg 2013; 71: 1261–1267. PubMed
Vinzenz K. Edema therapy in dental interventions with hydrolytic enzymes. Quintessenz 1991; 42: 1053–1064. PubMed
Tharani Kumar S, Ashok Prasanna R, Kirubanandan J, et al.. Postoperative healing after surgical removal of mandibular third molar: a comparative study between two proteolytic enzymes. J Pharm Bioallied Sci 2020; 12: S289–S294. PubMed PMC
Knackstedt R, Gatherwright J. Perioperative homeopathic arnica and bromelain: current results and future directions. Ann Plast Surg 2020; 84: e10–e15. PubMed
Kameníček V, Holáň P, Franěk P. Systemic enzyme therapy in the treatment and prophylaxis of posttraumatic swelling. Acta Chir Orthop Traumatol Cech 2001; 68: 45–49. PubMed
Isaeva AV, Minaev SV, Sternin. Modern approach to the rehabilitation of children with fractured long tubular bones. Vopr Kurortol Fizioter Lech Fiz Kult 2009; 3: 29–31. PubMed
Pekař L, Steindler J. Systémová enzymoterapie po operacích výhřezu bederní meziobratlové ploténky. Klin Farmakol Farm 2009; 23: 166–170.
Kerkhoffs GMMJ, Struijs PAA, de Wit C, et al.. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes. Br J Sports Med 2004; 38: 431–435. PubMed PMC
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg 1969; 51: 737–755. PubMed
Söderman P, Malchau H. Is the Harris hip score system useful to study the outcome of total hip replacement? Clin Orthop Relat Res 2001; 384: 189–197. PubMed
Swanenburg J, Gruber C, Brunner F, et al.. Patients’ and therapists’ perception of change following physiotherapy in an orthopedic hospital’s outpatient clinic. Physiother Theory Pract 2015; 31: 293–298. PubMed
Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health Education and Welfare, 1976, pp.217–222.
Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007; 4: 28–37. PubMed PMC
MUCOS Pharma GmbH. Phlogenzym, https://prehledy.sukl.cz/prehledy/v1/dokumenty/16280 (2022, accessed 10 July 2023).
Lovell TP. Single-incision direct anterior approach for total hip arthroplasty using a standard operating table. J Arthroplasty 2008; 23: 64–68. PubMed
Bayer AG. Xarelto (rivaroxaban) summary of product characteristics, https://www.ema.europa.eu/en/documents/product-information/xarelto-epar-product-information_en.pdf (2021, accessed 9 September 2021).
Frank AHR, Groene P, von Ehrlich-Treuenstatt V. Evaluation of pain relief sufficiency using the cumulative analgesic consumption score (CACS) and its modification (MACS). Wideochir Inne Tech Maloinwazyjne 2017; 12: 448–454. PubMed PMC
Kaur H, Corscadden K, Lott C, et al.. Bromelain has paradoxical effects on blood coagulability: a study using thromboelastography. Blood Coagul Fibrinolysis 2016; 27: 745–752. PubMed
State Institute for Drug Control. KLH-21 version 21: Reporting adverse reactions to medicinal products for human use in a clinical trial and to medicinal products without marketing authorisation, https://www.sukl.eu/medicines/klh-21-version-7 (2018, accessed 9 September 2021).
Krishna A, Garg S, Ghupta S, et al.. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) trends following total hip and knee arthroplasties in an Indian population – a prospective study. Malays Orthop J 2021; 15: 143–150. PubMed PMC
Shen H, Zhang N, Zhang X, et al.. C-reactive protein levels after 4 types of arthroplasty. Acta Orthop 2009; 80: 330–333. PubMed PMC
Azboy I, Çatal B, Başarır K, et al.. The natural course of serum D-Dimer, C-reactive protein, and erythrocyte sedimentation rate levels after uneventful primary total joint arthroplasty. J Arthroplasty 2021; 36: 3118–3122. PubMed
Cho MR, Choi WK, Jun CM, et al.. The natural trends of C-reactive protein after hip arthroplasty for femoral neck fracture without infection. Med 2021; 100: e27299. PubMed PMC
Lei Y, Huang Q, Xu B, et al.. Multiple low-dose dexamethasone further improves clinical outcomes following total hip arthroplasty. J Arthroplasty 2018; 33: 1426–1431. PubMed
Holm B, Kristensen MT, Husted H, et al.. Thigh and knee circumference, knee-extension strength, and functional performance after fast-track total hip arthroplasty. PMR 2011; 3: 117–124. PubMed
O’Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 2012; 10: 331–342. PubMed PMC
Azarkan M, González MM, Esposito RC, et al.. Stem bromelain proteolytic machinery: study of the effects of its components on fibrin (ogen) and blood coagulation. Protein Pept Lett 2020; 27: 1159–1170. PubMed
Johann K, Eschmann K, Meiser P. [No clinical evidence for an enhanced bleeding tendency due to perioperative treatment with bromelain]. Sportverletz Sportschaden 2011; 25: 108–113. PubMed
Melišík M, Hrubina M, Heřt J, et al.. [Mid-term results of Proxima ultra-short anatomical stem: analysis of 130 cases]. Acta Chir Orthop Traumatol Cech 2021; 88: 50–57. PubMed